More News! Will BMS be acquired? “CRISPR babies aren’t unethical”?

Try as we might, we can’t cover all the biotech news out there! Here’s a roundup of news that didn’t make the cut this week.

ANGHI

  • Pfizer has launched an appeal of its record-breaking fine from the NHS
  • Sartorius has joined the European Molecular Biology Laboratory

Seregraff

  • Immunicum gets a green light to include France in its ongoing Phase II trial for metastatic renal cell carcinoma
  • uniQure is officially initiating its 3-pronged approach targeting Hemophilia B, congestive heart failure and Huntington’s disease.

Riku Heikkila

  • The National Academy of Sciences and the National Academy of Medicine don’t seem to think CRISPR editing genomes is so unethical after all
  • Though it’s unclear if that opinion affects the new report from Grand View Research, CRISPR/Cas could represent a €3.9B market by 2025

Cat or Dulce de Leche?

CdjJWcpUUAAn4Bc


Images from Ol41ka, ANGHI, Seregraff, Riku Heikkila / shutterstock.com

Let's Continue The Conversation

Feel free to send us comments about this article to [email protected] and/or comment on that article on social media.

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.